Search Results - "Döcke, W D"

Refine Results
  1. 1

    Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases by Schäcke, H, Zollner, TM, Döcke, WD, Rehwinkel, H, Jaroch, S, Skuballa, W, Neuhaus, R, May, E, Zügel, U, Asadullah, K

    Published in British journal of pharmacology (01-10-2009)
    “…Background and purpose:  Glucocorticoids are highly effective in the therapy of inflammatory diseases. Their value, however, is limited by side effects. The…”
    Get full text
    Journal Article
  2. 2

    Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms by von Lanzenauer, S H, Wolk, K, Höflich, C, Kunz, S, Grünberg, B H, Döcke, W-D, Reineke, U, Asadullah, K, Sterry, W, Volk, H-D, Sabat, R

    Published in Genes and immunity (01-01-2015)
    “…Interleukin (IL)-10 is an important immunoregulatory cytokine that mediates its effects via a transmembrane receptor complex consisting of two different…”
    Get full text
    Journal Article
  3. 3

    Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis by Döcke, W.-D., Kiessling, C., Worm, M., Friedrich, M., Pruss, A., Weitz, M., Prösch, S., Kern, F., Volk, H-D., Sterry, W., Asadullah, K.

    Published in British journal of dermatology (1951) (01-05-2003)
    “…Summary Background Microbiological infections are considered to be of pathophysiological importance in atopic dermatitis (AD). As yet, no information is…”
    Get full text
    Journal Article
  4. 4

    Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation by von Baehr, V, Döcke, W-D, Plauth, M, Liebenthal, C, Küpferling, S, Lochs, H, Baumgarten, R, Volk, H-D

    Published in Gut (01-08-2000)
    “…BACKGROUND In patients with alcoholic liver cirrhosis, endotoxaemia is a frequent finding. Unknown mechanisms, however, prevent typical clinical symptoms of…”
    Get full text
    Journal Article
  5. 5

    Interleukin-10 in cutaneous disorders : implications for its pathophysiological importance and therapeutic use by ASADULLAH, K, SABAT, R, WIESE, A, DÖCKE, W.-D, VOLK, H.-D, STERRY, W

    Published in Archives of Dermatological Research (01-12-1999)
    “…With its antiinflammatory and immunosuppressive properties interleukin-10 (IL-10) plays a dominant role in several immune reactions including regulatory…”
    Get full text
    Journal Article
  6. 6

    IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression by Asadullah, K., Haeußler-Quade, A., Gellrich, S., Hanneken, S., Hansen-Hagge, T. E., Döcke, W.-D., Volk, H.-D., Sterry, W.

    Published in Experimental dermatology (01-08-2000)
    “…: Cytokines are of major importance for the pathogenesis of cutaneous T‐cell lymphomas (CTCL). Recent data suggested that IL‐15 and IL‐16 are survival/growth…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Erratum: Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms by von Haehling, S, Wolk, K, Höflich, C, Kunz, S, Grünberg, B H, Döcke, W-D, Reineke, U, Asadullah, K, Sterry, W, Volk, H-D, Sabat, R

    Published in Genes and immunity (01-07-2015)
    “…Correction to: Genes and Immunity (2015) 16, 8–14; doi:10.1038/gene.2014.69; published online 4 December 2014 Following the publication of this paper, the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Very low monocytic HLA-DR expression indicates high risk of infection--immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy by Asadullah, K, Woiciechowsky, C, Döcke, W D, Egerer, K, Kox, W J, Vogel, S, Sterry, W, Volk, H D

    Published in European journal of emergency medicine (01-12-1995)
    “…In patients with disturbed immunoreactivity caused by trauma or immunosuppressive therapy infections are still a severe problem. To determine whether…”
    Get more information
    Journal Article
  11. 11

    IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach by Asadullah, K, Sterry, W, Stephanek, K, Jasulaitis, D, Leupold, M, Audring, H, Volk, H D, Döcke, W D

    Published in The Journal of clinical investigation (15-02-1998)
    “…Overexpression of proinflammatory, type 1 cytokines has been demonstrated in psoriasis and is believed to be of pathophysiological importance. IL-10 is a type…”
    Get full text
    Journal Article
  12. 12

    Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type by Schoenbein, C, Docke, W.-D, Wolk, K, Belbe, G, Hoflich, C, Jung, M, Grutz, G, Sterry, W, Volk, H.-D, Asadullah, K, Sabat, R

    Published in Clinical and experimental immunology (01-02-2008)
    “…Interleukin (IL)-10 is one of the most crucial immunoregulatory cytokines. Its short-term effects have been analysed extensively, but little is known about its…”
    Get full text
    Journal Article
  13. 13

    Hemodynamic effects of Immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy three-month results from a randomized study by FELIX, S. B, STAUDT, A, WALLUKAT, G, STANGL, K, BAUMANN, G, DÖRFFEL, W. V, STANGL, V, MERKEL, K, POHL, M, DOCKE, W. D, MORGERA, S, NEUMAYER, H. H, WERNECKE, K. D

    “…The objective of our study was to assess the hemodynamic effects of immunoadsorption (IA) and subsequent immunoglobulin G (IgG) substitution in comparison with…”
    Get full text
    Journal Article
  14. 14

    Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers by HARTUNG, T, DÖCKE, W.-D, GANTNER, F, KRIEGER, G, SAUER, A, STEVENS, P, VOLK, H.-D, WENDEL, A

    Published in Blood (01-05-1995)
    “…We explored the ex vivo alteration in the cytokine release of stimulated blood taken from healthy volunteers treated subcutaneously with 480 micrograms…”
    Get full text
    Journal Article
  15. 15

    Cytomegalovirus reactivation and tumour necrosis factor by Döcke, W D, Prösch, S, Fietze, E, Kimel, V, Zuckermann, H, Klug, C, Syrbe, U, Krüger, D H, von Baehr, R, Volk, H D

    Published in The Lancet (British edition) (29-01-1994)
    “…Tumour necrosis factor-alpha (TNF) stimulates cytomegalovirus (CMV) activity in a transfected human monocytic cell line. We assessed whether this finding is…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Monocyte deactivation--rationale for a new therapeutic strategy in sepsis by Volk, H D, Reinke, P, Krausch, D, Zuckermann, H, Asadullah, K, Müller, J M, Döcke, W D, Kox, W J

    Published in Intensive care medicine (01-10-1996)
    “…Inflammatory cells, in particular monocytes/macrophages, release pro-inflammatory mediators in response to several infectious and non-infectious stimuli. The…”
    Get full text
    Journal Article
  19. 19

    Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression by WOICIECHOWSKY, C, SCHÖNING, B, LANKSCH, W. R, VOLK, H.-D, DÖCKE, W.-D

    “…Overwhelming inflammatory immune response can result in systemic inflammation and septic shock. To prevent excessive and deleterious action of proinflammatory…”
    Get full text
    Journal Article
  20. 20

    Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody by Lehmann, M, Sternkopf, F, Metz, F, Brock, J, Döcke, W D, Plantikow, A, Kuttler, B, Hahn, H J, Ringel, B, Volk, H D

    Published in Transplantation (01-12-1992)
    “…The new monoclonal antirat CD4 antibody RIB 5/2, which detects another epitope than those covered by W3/25 and MRC OX35, was tested for its immunosuppressive…”
    Get more information
    Journal Article